Announcements Trials
Browse Landscape

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Genitourinary 2Endocrine 1

Conditions

Neoplasms 518Breast Neoplasms 454Lung Neoplasms 252Prostatic Neoplasms 234Colorectal Neoplasms 216Carcinoma, Non-Small-Cell Lung 185Pancreatic Neoplasms 154Carcinoma, Hepatocellular 136Stomach Neoplasms 134Ovarian Neoplasms 116Multiple Myeloma 98Melanoma 93Head and Neck Neoplasms 92Esophageal Neoplasms 90Disease 87Urinary Bladder Neoplasms 85Uterine Cervical Neoplasms 78Lymphoma 78Brain Neoplasms 75Liver Neoplasms 74Hematologic Neoplasms 74Endometrial Neoplasms 71Leukemia, Myeloid, Acute 66Neoplasm Metastasis 65Colonic Neoplasms 61Rectal Neoplasms 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Glioma 54Sarcoma 53Leukemia 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × Hereditary leiomyomatosis and renal cell cancer × Clear all
NCT00001238 2026-05-22

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
EndocrineGenitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms, Pheochromocytoma

NCT03749980 2024-04-26

MyVHL

VHL Alliance

Recruiting
10,000 enrolled
Genitourinary

Hereditary leiomyomatosis and renal cell cancer, von Hippel-Lindau Disease, Birt-Hogg-Dube Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡